1. Home
  2. DUOT vs UNCY Comparison

DUOT vs UNCY Comparison

Compare DUOT & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • UNCY
  • Stock Information
  • Founded
  • DUOT 1990
  • UNCY 2016
  • Country
  • DUOT United States
  • UNCY United States
  • Employees
  • DUOT N/A
  • UNCY N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOT Technology
  • UNCY Health Care
  • Exchange
  • DUOT Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • DUOT 66.3M
  • UNCY 58.7M
  • IPO Year
  • DUOT N/A
  • UNCY 2021
  • Fundamental
  • Price
  • DUOT $5.22
  • UNCY $0.55
  • Analyst Decision
  • DUOT Strong Buy
  • UNCY Strong Buy
  • Analyst Count
  • DUOT 2
  • UNCY 3
  • Target Price
  • DUOT $10.75
  • UNCY $6.50
  • AVG Volume (30 Days)
  • DUOT 79.5K
  • UNCY 925.3K
  • Earning Date
  • DUOT 03-31-2025
  • UNCY 05-12-2025
  • Dividend Yield
  • DUOT N/A
  • UNCY N/A
  • EPS Growth
  • DUOT N/A
  • UNCY N/A
  • EPS
  • DUOT N/A
  • UNCY N/A
  • Revenue
  • DUOT $7,280,885.00
  • UNCY N/A
  • Revenue This Year
  • DUOT $16.88
  • UNCY N/A
  • Revenue Next Year
  • DUOT $183.85
  • UNCY $888.72
  • P/E Ratio
  • DUOT N/A
  • UNCY N/A
  • Revenue Growth
  • DUOT N/A
  • UNCY N/A
  • 52 Week Low
  • DUOT $2.03
  • UNCY $0.20
  • 52 Week High
  • DUOT $8.53
  • UNCY $1.60
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 39.94
  • UNCY 40.61
  • Support Level
  • DUOT $5.87
  • UNCY $0.60
  • Resistance Level
  • DUOT $6.38
  • UNCY $0.65
  • Average True Range (ATR)
  • DUOT 0.52
  • UNCY 0.05
  • MACD
  • DUOT -0.05
  • UNCY -0.01
  • Stochastic Oscillator
  • DUOT 35.96
  • UNCY 3.86

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

Share on Social Networks: